HIV and Hepatitis B Coinfection: Disease progression, epidemiology, and liver transplantation.

· 852. Inter- and Intra-genotypic Recombinations of HBV DNA in Subjects Coinfected by HIV

· 914. The Long-term Use of Tenofovir Disoproxil in HIV-HBV Co-infection Induces a Marked Decrease in Liver Fibrosis.

· 922. De Novo Combination Therapy of Tenofovir Disoproxil Fumarate (TDF) Plus Lamividine (LAM) or TDF Plus Emtricitabine (FTC) Is Associated with Early Virologic Response in HIV/HBV Co-infected Patients

· 938. Entecavir Monotherapy Selects M184V Mutation in Lamivudine-naïve and Lamivudine-experienced HIV-HBV Co-infected Patients

· 954. Baseline CD4+ T Cell Count Predicts HBV Decline in HIV Negative and Positive and Patients Treated with Adefovir Dipivoxil

· 967. Prior Lamivudine (LAM) Failure May Delay Time to Complete HBV-DNA Suppression in HIV Patients Treated with Tenofovir plus LAM